Related Experiment Video
Updated: Aug 22, 2025
Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer's Disease
Lukas Busch1, Simone Eggert2, Kristina Endres3
1Department of Informatics and Microsystems Technology, University of Applied Sciences Kaiserslautern, D-66482 Zweibruecken, Germany.
Abstract:
Recent advances have placed the pro-inflammatory activity of amyloid β (Aβ) on microglia cells as the focus of research on Alzheimer's Disease (AD). Researchers are confronted with an astonishing spectrum of over 100 different Aβ variants with variable length and chemical modifications. With the exception of Aβ1-42 and Aβ1-40, the biological significance of most peptides for AD is as yet insufficiently understood. We therefore aim to provide a comprehensive overview of the contributions of these neglected Aβ variants to microglia activation. First, the impact of Aβ receptors, signaling cascades, scavenger mechanisms, and genetic variations on the physiological responses towards various Aβ species is described. Furthermore, we discuss the importance of different types of amyloid precursor protein processing for the generation of these Aβ variants in microglia, astrocytes, oligodendrocytes, and neurons, and highlight how alterations in secondary structures and oligomerization affect Aβ neurotoxicity. In sum, the data indicate that gene polymorphisms in Aβ-driven signaling pathways in combination with the production and activity of different Aβ variants might be crucial factors for the initiation and progression of different forms of AD. A deeper assessment of their interplay with glial cells may pave the way towards novel therapeutic strategies for individualized medicine.
Insights
Alzheimer's Disease research focuses on amyloid beta (Aβ) variants beyond Aβ1-42 and Aβ1-40, exploring their role in microglia activation for new therapeutic strategies.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Alzheimer's Disease (AD) research increasingly focuses on the pro-inflammatory role of amyloid beta (Aβ) in microglia.
- Over 100 Aβ variants exist, but the significance of most, beyond Aβ1-42 and Aβ1-40, remains poorly understood.
Purpose of the Study:
- To provide a comprehensive overview of how neglected Aβ variants contribute to microglia activation in AD.
- To explore the impact of Aβ receptors, signaling, scavenger mechanisms, and genetic variations on microglial responses to diverse Aβ species.
Main Methods:
- Review of existing literature on Aβ variants, microglia activation, and AD pathogenesis.
- Analysis of amyloid precursor protein processing pathways and their role in generating Aβ variants.
- Examination of how secondary structure and oligomerization influence Aβ neurotoxicity.
Main Results:
- Gene polymorphisms in Aβ-signaling pathways and the production/activity of various Aβ variants are critical in AD initiation and progression.
- Different Aβ species elicit distinct responses from microglia, influenced by receptors and signaling cascades.
- Alterations in Aβ secondary structure and oligomerization significantly impact neurotoxicity.
Conclusions:
- Understanding the interplay between diverse Aβ variants and glial cells is crucial for developing novel AD therapeutics.
- Individualized medicine approaches for AD may benefit from considering specific Aβ variant profiles and genetic predispositions.
- Further research into neglected Aβ variants and their glial interactions can unlock new therapeutic targets for Alzheimer's Disease.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:22Alzheimer's Disease: Treatment